Patent 9814670 was granted and assigned to Mary Kay Inc. on November, 2017 by the United States Patent and Trademark Office.
Disclosed are compositions and methods for their use that include a combination of Rhododendron ferrugineum (alpine rose) extract, Oenothera biennis (evening rose) extract, trifluoroacetyl tripeptide-2, and a cosmetic acceptable vehicle.